Aligos Therapeutics (ALGS)

• Market cap: $41M
• 1 day: 9.72%
• 5 days: -7.63%
• 1 month: -31.06%
• 3 months: -12.25%
• 6 months: 19.78%
• Year to date: -83.27%
• 1 year: -65.78%
• 5 years: -98.73%
• 10 years: -98.21%
• Sector: Healthcare
• Industry: Biotechnology

About: Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Employees: 70